Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MME | P08473 | 6/20 | 0.51 |
| ▸ | TGFBR1 | P36897 | 3/20 | 0.50 |
| ▸ | NOD1 | Q9Y239 | 1/20 | 0.44 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.44 |
| ▸ | ACE | P12821 | 1/20 | 0.43 |
| ▸ | DPP4 | P27487 | 1/20 | 0.42 |
| ▸ | ECE1 | P42892 | 1/20 | 0.39 |
| ▸ | CA2 | P00918 | 2/20 | 0.38 |
| ▸ | CA1 | P00915 | 1/20 | 0.38 |
| ▸ | DPP8 | Q6V1X1 | 1/20 | 0.38 |
| ▸ | DPP7 | Q9UHL4 | 1/20 | 0.38 |
| ▸ | CTRB1 | P17538 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30552905 | 1.00 | MME (0.51) | MMETGFBR1NOD1PAX8ACE | |
| SCHEMBL4561648 | 0.96 | MME (0.54) | MMETGFBR1NOD1PAX8ACE | |
| SCHEMBL7123863 | 0.96 | MME (0.54) | MMETGFBR1NOD1PAX8ACE | |
| SCHEMBL7123861 | 0.96 | MME (0.54) | MMETGFBR1NOD1PAX8ACE | |
| SCHEMBL4560840 | 0.96 | MME (0.54) | MMETGFBR1NOD1PAX8ACE | |
| SCHEMBL30416190 | 0.96 | MME (0.54) | MMETGFBR1NOD1PAX8ACE | |
| SCHEMBL29592597 | 0.93 | MME (0.46) | MMETGFBR1NOD1PAX8ACE | |
| SCHEMBL29630419 | 0.93 | MME (0.46) | MMETGFBR1NOD1PAX8ACE | |
| SCHEMBL26223895 | 0.91 | MME (0.47) | MMETGFBR1NOD1PAX8ACE | |
| SCHEMBL30099643 | 0.90 | MME (0.44) | MMETGFBR1NOD1PAX8ECE1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110041427-B | Anti-hepcidin antibodies and uses thereof | 本质生命科学有限公司 | 2023-05-23 | — | — | CN | disclosed |